Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Another veterinary anesthetic drug is showing up alongside fentanyl in Massachusetts, warranting a community drug supply ...

If you’re using Ranitidine occasionally and haven’t experienced any issues, your doctor may still consider it acceptable. But if you’re concerned, there are other alternatives that do not carry the ...

Medically reviewed by Steffini Stalos, DOA vitamin B12 blood test is a reliable way to determine if you have adequate levels of this crucial nutrient. Vitamin B12 is essential for nerve function, ...

India to continue to allow the sale of Ranitidine, a drug under scrutiny for potential cancer risks due to NDMA impurities. Listen to Story Popular heartburn drug Ranitidine, long under scrutiny, will ...

Pharmacist reveals four common drugs they'er scared to prescribeA doctor has warned people about common prescription and over-the-counter drugs that could raise their risk of cancer.The disease, which ...

A widely used pharma drug Back in 2021, after reports in the Indian press pointed out how Ranitidine was still being sold in India, there were some murmurs from the government indicating that it ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer Boehringer Ingelheim, the second in the past two months.

A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Zantac Litigation Zantac was a prescription drug approved by the FDA in 1983 to treat acid reflux using the active ingredient ranitidine. After the patent expired in 1997, generic versions of the drug ...